Inability of serial fibrin monomer measurements to predict or exclude deep venous thrombosis in asymptomatic patients undergoing total knee arthroplasty

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 3, 2000, Pages 305-308

  Reber, Guido ^a   Blanchard, J ^b   Bounameaux, H ^a   Hoffmeyer, P ^a   Miron, M J ^a   Leyvraz, P F ^b   De Moerloose, P ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

Deep venous thrombosis; Fibrin degradation products; Fibrin monomer; Total knee arthroplasty

Indexed keywords

FIBRIN MONOMER;

ARTICLE; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; PHLEBOGRAPHY; PRIORITY JOURNAL; TOTAL KNEE REPLACEMENT;

ARTHROPLASTY, REPLACEMENT, KNEE; BIOLOGICAL MARKERS; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PREDICTIVE VALUE OF TESTS; THROMBOPHLEBITIS;

EID: 0034113923     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 1. Caliezi C, Fünfsinn N, Mauron T, Sulzer I, Ulrich M, Cottier C, et al. Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients. Thromb Haemost 1999; 81: 50-53.
2. 2. Reber G, Bounameaux H, Perrier A, de Moerloose P. Performances of the fibrin monomer tests for the exclusion of pulmonary embolism in symptomatic outpatients. Thromb Haemost 1999; 81: 221-223.
3. 3. Dempfle CE, Dollman M, Lill H, Puzzovio D, Dessauer A, Heene DL. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN. Blood Coag Fibrinol 1993; 4: 79-86.
4. 4. Vogel G, Demplfle CE, Spannagl M, Leskopf W. The value of quantitative fibrin monomer determination in the early diagnosis of postoperative deep vein thrombosis. Thromb Res 1996; 81: 241-251.
5. 5. Blanchard J, Meuwly J-Y, Leyvraz PF, Miron M-J, Bounameaux H, Hoffmeyer P, et al. Prevention of deep vein thrombosis after total knee replacement. J Bone Joint Surg Br 1999; 81-B: 654-659.
6. 6. Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch-Haehnle B, et al. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coag Fibrinol 1993; 4: 97-102.
7. 7. Hanley JA, McNeil BJ. The meaning and use of the area under the receiver operator characteristic (ROC) curve. Radiology 1982; 143: 29-36.
8. 8. Bounameaux H, de Moerloose P, Perrier A, Miron M-J. D-Dimer testing in suspected venous thromboembolism. Q J Med 1997; 90: 437-442.
9. 9. Perrier A, Bounameaux H, Morabia A, Slosman D, Didier D, Unger PF, et al. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study. Arch Intern Med 1996; 156: 531-536.
10. 10. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Slosman D, Didier D, et al. Noninvasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190-195.
11. 11. Raimondi P, Bongard O, de Moerloose P, Reber G, Waldvogel F, Bounameaux H. D-Dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res 1993; 69: 125-130.
12. 12. Bongard O, Wicky J, Peter R, Simonowska S, Vogel JJ, de Moerloose P, et al. D-Dimer plasma measurement in patients undergoing major hip surgery: use in prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res 1994; 74: 487-493.
13. 13. Cofrancesco E, Cortallero M, Corradi A, Ravasi F, Bertocchi F. Coagulation markers in the prediction of venous thrombosis after elective hip surgery. Thromb Haemost 1997; 77: 267-269.
14. 14. Jorgensen LN, Lind B, Hauch O, Leffers A, Albrecht-Beste E, Konradsen LA. Thrombin-antithrombin III complex and fibrin degradation products in plasma: surgery and postoperative deep vein thrombosis. Thromb Res 1990; 59: 69-76.
15. 15. Dunn ID, Hui AC, Triffit PD, Crozier AE, Gregg PJ, Sinclair ME, et al. Plasma D-dimer as a marker for postoperative deep venous thrombosis. A study after total hip or knee replacement. Thromb Haemost 1994; 72: 663-665.
16. 16. Bara L, Planes A, Samama M-M. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparine, to prevent deep vein thrombosis after hip surgery. Br J Haematol 1999; 104: 230-240.
17. 17. Bounameaux H, Miron M-J, Blanchard J, de Moerloose P, Leyvraz P-F. Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty. Blood Coag Fibrinol 1998; 9: 749-752.
18. 18. Pfitzner SA, Demplfle CE, Matsuda M, Heene DL. Fibrin in plasma of patients with intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight Factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Thromb Haemost 1997; 78: 1069-1078.
19. 19. Andersen BS. Postoperative activation of the haemostatic system. Influence of prolonged thromboprophylaxis in patients undergoing total hip arthroplasty. Haemostasis 1997; 27: 219-227.